ATARA BIOTHERAPEUTICS INC (ATRA)
US0465131078 - Common Stock
ChartMill assigns a Buy % Consensus number of 73% to ATRA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.01. This target is 738.61% above the current price.
ATRA was analyzed by 15 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about ATRA.
In the previous month the buy percentage consensus was at a similar level.
ATRA was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-21 | Citigroup | Maintains | Sell -> Sell |
| 2023-08-09 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-06-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-09 | Canaccord Genuity | Maintains | Buy |
| 2023-02-09 | EF Hutton | Reiterate | Buy |
| 2023-02-09 | HC Wainwright & Co. | Maintains | Buy |
| 2023-02-07 | Mizuho | Reiterate | Buy |
| 2023-01-05 | EF Hutton | Initiate | Buy |
| 2022-08-16 | Mizuho | Maintains | Buy |
| 2022-08-09 | Goldman Sachs | Maintains | Sell |
| 2022-07-20 | Citigroup | Downgrade | Neutral -> Sell |
| 2022-07-13 | Stifel | Downgrade | Buy -> Hold |
| 2022-07-13 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2022-05-24 | Goldman Sachs | Maintains | Sell |
| 2022-05-23 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-10 | Citigroup | Downgrade | Buy -> Neutral |
| 2022-01-03 | JP Morgan | Maintains | Overweight |
| 2021-05-13 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2021-05-05 | HC Wainwright & Co. | Maintains | Buy |